Lung Cancer Foundation Lauds Carbone’s Innovative Research
March 26, 2010
BY: DAGNY STUART
Vanderbilt-Ingram Cancer Center’s David Carbone, M.D., Ph.D., has received the Dr. David Jablons “Asclepios” Award for his commitment to innovative research.
The award was presented during the Simply the Best Ever Dinner Gala by the Bonnie J. Addario Lung Cancer Foundation.
Addario is a five-year lung cancer survivor and founder of the San Francisco-based nonprofit foundation, which is one of the nation’s largest philanthropies devoted exclusively to eradicating lung cancer.
The foundation has raised nearly $4 million for the promotion of lung cancer research.
“Dr. Carbone is the epitome of what a great translational scientist and consummate physician should be: smart, driven, passionate, compassionate, humble and tireless,” said Jablons, M.D., director of the University of California San Francisco Thoracic Oncology Laboratory and one of the physicians who treated Addario.
“I am so honored to be recognized by this foundation, which is doing such important work to raise the profile of lung cancer and to support lung cancer research,” said Carbone, Harold L. Moses Professor of Cancer Research.
Carbone, professor of Medicine, Cell and Developmental Biology and Cancer Biology, is director and principal investigator of the VICC Specialized Project in Research Excellence (SPORE) in lung cancer.
He is director of the Experimental Therapeutics Program and the Thoracic Oncology Center at VICC. He also serves on the Board of Scientific Counselors for the National Cancer Institute as well as the NCI Thoracic Malignancies Steering Committee.
Carbone’s research interests are focused on lung cancer genetics, especially biomarker development, cancer immunotherapy, and tumor-associated immunosuppression mechanisms.
He is currently chair of the Scientific Leadership Board for the Addario Lung Cancer Medical Institute.